Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
AZD1446 in Adult ADHD
NCT01012375Phase 2Completed
- Sponsor
- AstraZeneca
- Start
- Nov 2009
- Primary completion
- Aug 2010
- Modality
- Small Molecules
- Countries
- 1
01
Overview
A Phase 2 trial of azd1446 in attention deficit hyperactivity disorder (ADHD), sponsored by AstraZeneca. Started Nov 2009; status: completed.
02
Drugs
azd1446
03
Conditions
attention deficit hyperactivity disorder (ADHD)
Beyond the preview
Go deeper on NCT01012375.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01012375.